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Diseased G Protein-coupled Receptors Editorial
One of the exciting scientific developments of the past few
years has been the elucidation of a number of features of the
structure, function, and regulation of the remarkable super-
family of G protein-coupled receptors (1). The diversity of
their functional roles is dazzling and includes signaling by pep-
tides, neurotransmitters (biogenic amines, acetylcholine, etc.),
lipids, chemoattractants, sensory stimuli, and cytokines. Many
of the structural features of the receptors are well established.
The characteristic seven transmembrane-spanning domains
form the ligand binding site, while the hydrophilic intracellular
loops and carboxy-terminal cytoplasmic tail contain sites of
interaction with G proteins and are often studded with phos-
phorylation sites for kinases, which regulate receptor func-
tion (1).
It might be expected that abnormalities of these proteins
would wreak very specific forms of pathophysiological havoc.
In this issue of The Journal, Tsigos et al. (2) demonstrate that a
youngster with a rare autosomal recessive disorder, isolated
glucocorticoid deficiency (IGD), has inherited two different
mutations in the gene for the ACTH receptor (2). The paternal
allele contains a point mutation that substitutes a positively
charged arginine for neutral serine in the third membrane
span, while the maternal allele encodes a receptor truncated
early in the third cytoplasmic loop. The authors speculate that
the first mutation may alter the ligand binding site ofthe recep-
tor while the second leads to a nonfunctional receptor. Sup-
porting these contentions, it was found that both heterozygote
parents had abnormal ovine corticotropin releasing hormone
tests suggestive of subclinical resistance to ACTH. Clark et al.
(3) have identified, in another family, a mutation in the ACTH
receptor in IGD, a substitution ofisoleucine for serine in trans-
membrane domain 2.
IGD is the second disease in which hormone resistance has
been shown to be due to defects in a G protein-coupled recep-
tor. Previously, nephrogenic diabetes insipidus was shown to
result from mutations in the gene for the V2 vasopressin recep-
tor (4, and references therein). In this case, a mutant receptor
has been expressed and shown to be defective in signal trans-
duction rather than in hormone binding (4). Similar analysis
should be performed for these ACTH receptor mutants.
Numerous further examples of alterations in G protein-
coupled receptors causing diseases likely will be found. What
mechanisms might be involved? Perhaps the most obvious is
disruption of receptor signaling, as shown now for ACTH and
vasopressin receptors. One can envisage alterations that disturb
either ligand binding or G protein coupling. Structural abnor-
malities of the receptor might also prevent its functional ex-
pression at the cell surface or lead to its intracellular accumula-
tion, as is the case with numerous rhodopsin mutations that
cause retinitis pigmentosa (5).
Point mutations have also been shown to lead to constitu-
tive activation of receptors, i.e., the receptor shows activity in
the absence of ligand (6). Such mutations could cause various
forms of cellular hyperfunction or even damage cells by their
overactivity. Thus, a constitutively active mutation ofrhodop-
sin leads to retinal degeneration (5).
Several G protein-coupled receptors are mitogenic and ca-
pable of transforming cells in vitro when agonist is present.
When such receptors are activated by mutations (in the third
cytoplasmic loop) they transform cells in an agonist-indepen-
dent fashion (i.e., they function as oncogenes) (7). Thus, this
mechanism could also lead, in appropriate contexts, to tumors
of various tissues. Mutations that eliminate key sites of regula-
tion (e.g., phosphorylation sites) might also lead to changes in
receptor functions.
Receptor mutations need not lead to disease states but
might also underly phenotypic variations within a population.
For example, the mouse coat color extension locus has been
identified with the MSH receptor gene. A truncated MSH re-
ceptor leads to light coat color, while activating mutations of
the receptor lead to dark coat color (8). A single amino acid
polymorphism in the human red iodopsin gene is responsible
for variation in spectral sensitivity to red light (9). Given the
recent pace ofprogress in this field many more such discoveries
will likely be forth coming in the near future.
Robert J. Lefkowitz and Richard T. Premont
Departments of Medicine and Biochemistry
Howard Hughes Medical Institute
Duke University Medical Center
References
1. Dohlman, H. G., J. Thorner, M. G. Caron, and R. J. Lefkowitz. 1991.
Model systems for the study of seven-transmembrane segment receptors. Annu.
Rev. Biochem. 60:653-688.
2. Tsigos, C., K. Arai, W. Hung, and G. P. Chrousos. 1993. Hereditary iso-
lated glucocorticoid deficiency is associated with abnormalities ofthe adrenocor-
ticotropin receptor gene. J. Clin. Invest. 92:2458-2461.
3. Clark, A. J. L., L. McLoughlin, and A. Grossman. 1993. Familial glucocor-
ticoid deficiency associated with point mutation in the adrenocorticotropin re-
ceptor. Lancet. 341:461-462.
4. Rosenthal, W., A. Antaramian, S. Gilbert, and M. Birnbaumer. 1993.
Nephrogenic diabetes insipidus. J. Biol. Chem. 268:13030-13033.
5. Min, K. C., T. A. Zvyaga, A. M. Cypress, and T. P. Sakmar. 1993. Charac-
terization of mutant rhodopsins responsible for autosomal dominant retinitis
pigmentosa. J. Bid. Chem. 268:9400-9404.
6. Samama, P., S. Cotecchia, T. Costa, and R. J. Lefkowitz. 1993. A muta-
tion-induced activated state of the #2-adrenergic receptor. J. Biol. Chem.
268:46254636.
7. Allen, L. F., R. J. Lefkowitz, M. G. Caron, and S. Cotecchia. 1991. G-pro-
tein-coupled receptor genes as protooncogenes. Proc. Natl. Acad. Sci. USA.
88:11354-11358.
8. Robbins, L. S., J. H. Nadeau, K. R. Johnson, M. A. Kelley, L. Roselli-Reh-
fuss, E. Baack, K. G. Mountjoy, and R. D. Cone. 1993. Pigmentation phenotypes
of variant extension locus alleles result from point mutations that alter MSH
receptor function. Cell. 72:827-834.
9. Winderickx, J., D. T. Lindsey, E. Sanocki, D. Y. Teller, A. G. Motulsky,
and S. S. Deeb. 1992. Polymorphism in red photopigment underlies variation in
colour matching. Nature (Lond.). 356:431435.
Diseased G Protein-coupled Receptors 2089
J. Clin. Invest.
© The American Society for Clinical Investigation, Inc.
0021-9738/93/11/2089/01 $2.00
Volume 92, November 1993, 2089
Downloaded on September 10, 2013.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/116806
